In addition, in the OV cohort, TRPM2 was also associated with several chemokines and chemokine receptors that have been shown to promote ovarian cancer progression and metastasis, such as CXCL11-CXCR3 and CXCL12-CXCR4 chemokine axes [36,37]. The gene discussed is CXCL11; the disease is ovarian carcinoma.